LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)
China · Delayed Price · Currency is CNY 7.77
+0.06 (0.78%)
Jul 30, 2026, 10:55 AM CST
SHE:002644 Revenue
LanZhou Foci Pharmaceutical had revenue of 211.57M CNY in the quarter ending March 31, 2026, a decrease of -2.11%. This brings the company's revenue in the last twelve months to 910.98M, down -1.20% year-over-year. In the year 2025, LanZhou Foci Pharmaceutical had annual revenue of 915.53M, down -6.60%.
Revenue (ttm)
910.98M
Revenue Growth
-1.20%
P/S Ratio
4.32
Revenue / Employee
683.92K
Employees
1,332
Market Cap
3.94B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 915.53M | -64.69M | -6.60% |
| Dec 31, 2024 | 980.23M | -182.91M | -15.73% |
| Dec 31, 2023 | 1.16B | 120.75M | 11.58% |
| Jan 1, 2023 | 1.04B | 224.75M | 27.49% |
| Jan 1, 2022 | 817.64M | 149.59M | 22.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jinling Pharmaceutical Company | 3.16B |
| Hunan Fangsheng Pharmaceutical | 1.79B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.78B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.68B |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 843.87M |
| Harbin Medisan Pharmaceutical | 813.23M |
| Nanjing Hicin Pharmaceutical | 688.74M |
| Newland Pharmaceutical | 659.54M |